{
  "name": "Varenicline",
  "type": "INANIMATE_OBJECT",
  "id": {
    "group": 20,
    "item": 1004
  },
  "claims": [
    {
      "predicate": "CAUSES",
      "object": "Reduced nicotine upregulation of a4b2-type nicotinic receptors",
      "temporal": {
        "valid_from": "2017",
        "valid_until": "PRESENT",
        "event": null
      },
      "epistemic": {
        "confidence": 0.8,
        "status": "SETTLED",
        "source_type": "ACADEMIC"
      }
    }
  ],
  "surface_layer": {
    "definition": "A medication used to treat nicotine addiction.",
    "common_uses": [
      "Treatment of nicotine addiction"
    ]
  },
  "deep_layer": {
    "mechanism": "Acts as a partial agonist at nicotinic acetylcholine receptors.",
    "origin": "Pharmaceutical synthesis."
  },
  "instance_layer": {
    "examples": []
  },
  "facets": {},
  "epistemic_metadata": {
    "source": "Ingestion Engine",
    "citations": []
  }
}